Please login to the form below
GlycoVaxyn
This page shows the latest GlycoVaxyn news and features for those working in and with pharma, biotech and healthcare.
GSK's pivotal TB vaccine could prevent millions of deaths
GSK has made vaccines a pillar of its strategy since taking control of Novartis’ vaccine business in 2014, which it then followed up with a $190m deal for vaccine specialist GlycoVaxyn
Latest news
-
GSK buys vaccine specialist GlycoVaxyn for $190m
Acquisition will expand GSK’s early vaccines pipeline. . GlaxoSmithKline (GSK) has taken control of Swiss company GlycoVaxyn in a $190m deal that bolsters its early vaccines pipeline. ... GSK already owned a stake in GlycoVaxyn and had been working
-
Janssen boosts vaccines pipeline with GlycoVaxyn deal
He said: “This collaboration is a further confirmation of the position GlycoVaxyn is about to occupy in the vaccine development space. ... The whole team is dedicated to establish GlycoVaxyn's technology as a powerful platform able to generate
More from news
Approximately 2 fully matching, plus 1 partially matching documents found.
Latest Intelligence
-
Medius Deal Watch table for February 2015
Licence. 201. GlycoVaxyn/ GSK. Conjugation platform plus early stage vaccines against bacterial infections such as pneumonia, Pseudomonas, S.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest appointments
-
GlycoVaxyn appoints Gerd Zettlmeissl as chairman
He will join the Swiss vaccines company in June. Swiss vaccines company GlycoVaxyn has appointed Gerd Zettlmeissl as chairman of the board of directors with effect from June, when he will
More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Account Manager - Creative Healthcare Communications - South Wes...
-
Excellent Remuneration
-
Account Management
-
Competitive Salary Offered
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
-
Account Manager
-
Competitive Salary
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Head of Strategic Planning, Healthcare Advertising/ Brand comms,...
-
Six figure salary
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- Senior Medical Writer– Medical Education – Oxford - London
-
Excellent Remuneration Package
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Manager/ Account Director
-
Competitive Salary Offered
-
Senior Account Executive
-
Competitive Salary
-
Senior Medical Writer
-
Competitive Salary
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Senior & Principal Medical Writer
-
Competitive Salary Offered
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- Group Account Director, Healthcare Advertising/ Brand comms, Lon...
-
8 month contract up to £90K
-
Medical Editor
-
Competitive Salary
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
-
Associate Account Director
-
Competitive Salary
-
Publications Director
-
Competitive Salary
- Novavax is close to finalising a COVID-19 vaccine supply deal with the EU
- CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval
- Merck & Co reveals plans for women’s health spinoff Organon
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- Single dose of COVID-19 vaccines ‘significantly’ reduces infections
- bluebird bio aiming to separate business units by year-end
- InSite Events™ selected as an honorable mention in Fast Company’s 2021 World Changing Ideas Awards
- THE HIDDEN LIFESAVERS: overdose prevention campaign launches nationwide
- Moderna’s booster vaccines increase neutralising antibodies against COVID-19 variants
- FDA approval for Keytruda/Herceptin combination in first-line advanced gastric cancer
- US backs proposal to waive IP protection for COVID-19 vaccines
- Nanobiotechnology, Artificial Intelligence, and Virtual Care
- Why female mentorship is so powerful in pharma
- CanSinoBIO considers booster jab for COVID-19 vaccine
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Moderna COVID-19 vaccine shortfall could affect UK supply
- NICE sets out plans for ‘ambitious’ five-year strategy
- Working in true partnership in a time of change
PMHub
Nucleus Global
Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...
Latest intelligence
- How can we strike the right balance between familiarity and innovation when it comes to data presentation?
- Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
- Deep 6 AI: the smart software breathing new life into clinical trials
- Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
- COVID-proof: How Teams are Creating Launch Intensity thru Adversity
- Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....
